Department of Health Policy and Management, University of North Carolina at Chapel Hill, McGavran-Greenberg Hall, Campus Box 7411, Chapel Hill, NC, 27599-7411, USA.
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Qual Life Res. 2024 Dec;33(12):3435-3447. doi: 10.1007/s11136-024-03802-0. Epub 2024 Oct 12.
The Geriatric Depression Scale (GDS) is widely used to screen for depression in clinical practice and to assess symptoms of depression in research about older adults. To determine whether the 15-item GDS can be used in adults with dementia, this study investigated whether item- or test-level bias in the GDS-15 is associated with the respondent's level of cognitive impairment.
Using a large U.S. sample of 24,674 adults, we first conducted sample matching procedures between the five groups defined by CDR® Dementia Staging Instrument scores to control for potential confounding effects of common demographic variables. Then, we employed confirmatory factor analysis (for single-group and configural-invariance models only) and item response theory models to test potential differential item/test functioning effects associated with the GDS-15 across the five CDR groups. Practical consequences of the identified biases were quantified using sample-based Cohen's d effect sizes and misclassification rates.
In general, people with higher CDR scores were older and had fewer years of education. In comparison to the normal cognition group (CDR-0), negligible biases in GDS-15 scores were found for the groups with questionable, mild, or moderate cognitive impairment (CDR-0.5/1/2). For individuals with severe cognitive impairment (CDR-3), their responses were inconsistent with the normal cognition group and their depression scores were significantly biased with a small-to-medium effect size.
The GDS-15 can be used to assess depression in individuals with mild or moderate cognitive impairment, but not in individuals with severe cognitive impairment.
老年抑郁量表(GDS)广泛用于临床实践中的抑郁筛查,并评估老年人相关研究中抑郁症状。为了确定 15 项 GDS 是否可用于痴呆症患者,本研究调查了 GDS-15 中项目或测试水平的偏差是否与患者的认知障碍程度相关。
本研究使用了美国 24674 名成年人的大型样本,首先在 CDR® 痴呆分期工具评分定义的五个组之间进行样本匹配程序,以控制常见人口统计学变量的潜在混杂影响。然后,我们采用验证性因子分析(仅用于单组和结构不变性模型)和项目反应理论模型来测试与 GDS-15 相关的潜在差异项目/测试功能效应,跨越五个 CDR 组。通过基于样本的 Cohen's d 效应大小和分类错误率来量化已识别偏差的实际后果。
一般来说,CDR 评分较高的人年龄较大,受教育年限较少。与正常认知组(CDR-0)相比,在有可疑、轻度或中度认知障碍的组(CDR-0.5/1/2)中,GDS-15 评分的偏差可忽略不计。对于认知障碍严重的个体(CDR-3),他们的反应与正常认知组不一致,其抑郁评分存在显著偏差,具有小到中等的效应大小。
GDS-15 可用于评估轻度或中度认知障碍患者的抑郁,但不能用于评估严重认知障碍患者。